DaVita Inc. (NYSE:DVA) Stock Holdings Trimmed by Texas Permanent School Fund Corp

Texas Permanent School Fund Corp cut its stake in shares of DaVita Inc. (NYSE:DVA) by 26.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,209 shares of the company’s stock after selling 2,924 shares during the quarter. Texas Permanent School Fund Corp’s holdings in DaVita were worth $1,138,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in the stock. Blue Trust Inc. boosted its position in shares of DaVita by 58.6% during the second quarter. Blue Trust Inc. now owns 211 shares of the company’s stock worth $29,000 after buying an additional 78 shares during the period. Newbridge Financial Services Group Inc. acquired a new position in shares of DaVita during the fourth quarter worth approximately $30,000. Principal Securities Inc. acquired a new position in shares of DaVita during the fourth quarter worth approximately $37,000. Family Firm Inc. acquired a new position in shares of DaVita during the second quarter worth approximately $43,000. Finally, Versant Capital Management Inc boosted its position in shares of DaVita by 90.6% during the second quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock worth $45,000 after buying an additional 155 shares during the period. 90.12% of the stock is owned by institutional investors.

DaVita Stock Performance

DVA opened at $164.00 on Friday. The company has a market capitalization of $14.38 billion, a price-to-earnings ratio of 18.64, a price-to-earnings-growth ratio of 0.95 and a beta of 0.87. The company has a debt-to-equity ratio of 9.94, a current ratio of 1.16 and a quick ratio of 1.12. DaVita Inc. has a 1-year low of $71.51 and a 1-year high of $166.04. The business has a 50 day moving average price of $147.19 and a two-hundred day moving average price of $140.85.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $2.59 EPS for the quarter, beating analysts’ consensus estimates of $2.47 by $0.12. DaVita had a return on equity of 77.00% and a net margin of 6.86%. The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.15 billion. During the same quarter in the prior year, the firm earned $2.08 EPS. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. Research analysts predict that DaVita Inc. will post 9.99 EPS for the current fiscal year.

Insider Activity

In other news, insider Kathleen Alyce Waters sold 7,857 shares of the stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the completion of the sale, the insider now owns 83,011 shares in the company, valued at approximately $12,137,038.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other DaVita news, CEO Javier Rodriguez sold 50,000 shares of the business’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the sale, the chief executive officer now directly owns 837,835 shares of the company’s stock, valued at approximately $138,284,666.75. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Kathleen Alyce Waters sold 7,857 shares of the business’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the sale, the insider now directly owns 83,011 shares in the company, valued at $12,137,038.31. The disclosure for this sale can be found here. In the last 90 days, insiders sold 173,482 shares of company stock worth $27,387,069. Insiders own 2.00% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on DVA shares. Truist Financial boosted their price objective on DaVita from $150.00 to $165.00 and gave the stock a “hold” rating in a research report on Tuesday, August 20th. Bank of America boosted their price objective on DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research report on Wednesday, August 7th. StockNews.com downgraded DaVita from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 8th. UBS Group upped their target price on DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Finally, TD Cowen upped their target price on DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a research report on Wednesday, July 24th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, DaVita has an average rating of “Hold” and an average price target of $157.00.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.